Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Has anyone heard news concerning the progress of Phase III clinincal trials for this BioMed stock? The street concensus is that this company is a strong buy, but its value is close to its low for the year. There really hasn't been any news for several months. I think DCRN is a keeper, but wish I had more timely information on it.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.